MBP
Click for more information
3.23% 3.0¢ metabolic pharmaceuticals limited

acv1 shows efficacy in trial, page-5

  1. KOKO
    1,358 Posts.
    lightbulb Created with Sketch. 8
    clock Created with Sketch.
    01/08/07
    23:41
    Post #: 2676390
    Thanks very much Jev for that follow up
    all research so far published, papers , journals and scientific reports are pointing to similar findings regarding Acv1 l look forward as do many others when the results are relesed and we can confirm the benefits for patients and the potential blockbuster status of this compound.
    MBP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.